A Randomized Double Blinded Controlled Trial on the Efficacy of TAP Block in Cesarean Section Patients When Compared to Placebo

New York Presbyterian Brooklyn Methodist Hospital1 site in 1 country60 target enrollmentJune 2013

ConditionsPain Control

Overview

Phase: Phase 3
Intervention: Not specified
Conditions: Pain Control
Sponsor: New York Presbyterian Brooklyn Methodist Hospital
Enrollment: 60
Locations: 1
Primary Endpoint: Effect of Transversus Abdominis Plane (TAP) Block Using Either 0.5% or 0.25% Bupivacaine on Analgesia for Cesarean Section Patients When Compared to Placebo.
Status: Completed
Last Updated: 7 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

TAP Block done with 2 different concentrations of bupivacaine and placebo

Detailed Description

TAP Block was done using 2 different concentrations of bupivacaine (0.5% and 0.25%) and placebo and the post operative sedation was measured in each arm and compared together.

Registry

clinicaltrials.gov

Start Date

June 2013

End Date

December 2013

Last Updated

7 years ago

Study Type

Interventional

Study Design

Parallel

Sex

Female

Investigators

Sponsor

New York Presbyterian Brooklyn Methodist Hospital

Responsible Party

Principal Investigator

Joel Yarmush

New York Presbyterian Brooklyn Methodist Hospital

Eligibility Criteria

Inclusion Criteria

•Healthy pregnant women

Exclusion Criteria

•Allergy to local anesthetics

Outcomes

Primary Outcomes

Effect of Transversus Abdominis Plane (TAP) Block Using Either 0.5% or 0.25% Bupivacaine on Analgesia for Cesarean Section Patients When Compared to Placebo.

Time Frame: 0-24 hours

The total the number of Patient Controlled Analgesia (PCA) boluses used by the patients postoperatively within 24 hours